These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9165638)

  • 61. Outcome of schizoaffective disorder at two long-term follow-ups: comparisons with outcome of schizophrenia and affective disorders.
    Grossman LS; Harrow M; Goldberg JF; Fichtner CG
    Am J Psychiatry; 1991 Oct; 148(10):1359-65. PubMed ID: 1897617
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline].
    Vanderzeypen F; Bier JC; Genevrois C; Mendlewicz J; Lotstra F
    Encephale; 2003; 29(2):172-80. PubMed ID: 14567169
    [TBL] [Abstract][Full Text] [Related]  

  • 63. First-episode psychosis: an epidemiological survey comparing psychotic depression with schizophrenia.
    Crebbin K; Mitford E; Paxton R; Turkington D
    J Affect Disord; 2008 Jan; 105(1-3):117-24. PubMed ID: 17574683
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The EPPIC follow-up study of first-episode psychosis: longer-term clinical and functional outcome 7 years after index admission.
    Henry LP; Amminger GP; Harris MG; Yuen HP; Harrigan SM; Prosser AL; Schwartz OS; Farrelly SE; Herrman H; Jackson HJ; McGorry PD
    J Clin Psychiatry; 2010 Jun; 71(6):716-28. PubMed ID: 20573330
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Treatment response in psychotic patients classified according to social and clinical needs, drug side effects, and previous treatment; a method to identify functional remission.
    Alenius M; Hammarlund-Udenaes M; Hartvig P; Sundquist S; Lindström L
    Compr Psychiatry; 2009; 50(5):453-62. PubMed ID: 19683616
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Survival of patients with severe mental disorders: Influence of social functioning.
    Vázquez-Reyes A; Martín-Rodríguez A; Pérez-San-Gregorio MÁ; Vázquez-Morejón AJ
    Int J Soc Psychiatry; 2023 Aug; 69(5):1157-1165. PubMed ID: 36708399
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Costs versus benefits and impact on life goals should be part of communication around anti-psychotic treatment duration in schizophrenia.
    Bendall S
    Aust N Z J Psychiatry; 2019 Aug; 53(8):811-812. PubMed ID: 31282188
    [No Abstract]   [Full Text] [Related]  

  • 68. Invited response to commentary. Small numbers are not predictive: Congenital blindness may or may not be protective for schizophrenia.
    Morgan VA; Badcock JC; Di Prinzio P; Ambrosi T; Clark M; Valuri G; Jablensky A
    Schizophr Res; 2019 Jul; 209():272-273. PubMed ID: 31088702
    [No Abstract]   [Full Text] [Related]  

  • 69. Schizophrenia and metabolic dysregulation: shared roots?
    Hasnain M
    Lancet Psychiatry; 2016 Nov; 3(11):1003-1005. PubMed ID: 27720401
    [No Abstract]   [Full Text] [Related]  

  • 70. Cortical Hub Failure in Schizophrenia.
    Patel GH
    Biol Psychiatry; 2018 Nov; 84(9):e65-e66. PubMed ID: 30297024
    [No Abstract]   [Full Text] [Related]  

  • 71. The non-psychotic residue in schizophrenia.
    DAVIE JM; FREEMAN T
    Br J Med Psychol; 1961; 34():117-27. PubMed ID: 13720075
    [No Abstract]   [Full Text] [Related]  

  • 72. 7th European Conference on Schizophrenia Research - Schizophrenia and other psychotic disorders: Time for precision medicine? : 26-28 September 2019, Berlin, Germany.
    Eur Arch Psychiatry Clin Neurosci; 2019 Sep; 269(Suppl 1):1-101. PubMed ID: 31444565
    [No Abstract]   [Full Text] [Related]  

  • 73. The social outcome of early schizophrenia.
    SHEPHERD M
    Psychiatr Neurol (Basel); 1959 Apr; 137(4):224-9. PubMed ID: 13667984
    [No Abstract]   [Full Text] [Related]  

  • 74. The Overlooked Part of Flexible Assertive Community Treatment-A Retrospective Study on Factors Related to Discharge from FACT for Clients with a Psychotic Disorder.
    de Bruijn E; Jochems EC; Wierdsma AI; Voskes Y
    Community Ment Health J; 2023 Oct; 59(7):1313-1320. PubMed ID: 37086300
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Predictors of admission to an assertive outreach service for psychosis in Lebanon.
    Kassir G; El Hayek S; Charara R; Cherro M; Itani H; El Khoury J
    PLOS Glob Public Health; 2022; 2(12):e0001428. PubMed ID: 36962861
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Hippocampal Hyperconnectivity to the Visual Cortex Predicts Treatment Response.
    Nelson EA; Kraguljac NV; Maximo JO; Armstrong W; Lahti AC
    Schizophr Bull; 2023 May; 49(3):605-613. PubMed ID: 36752830
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Psychotic symptoms in bipolar disorder and their impact on the illness: A systematic review.
    Chakrabarti S; Singh N
    World J Psychiatry; 2022 Sep; 12(9):1204-1232. PubMed ID: 36186500
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Designing a Clinician-Facing Tool for Using Insights From Patients' Social Media Activity: Iterative Co-Design Approach.
    Yoo DW; Birnbaum ML; Van Meter AR; Ali AF; Arenare E; Abowd GD; De Choudhury M
    JMIR Ment Health; 2020 Aug; 7(8):e16969. PubMed ID: 32784180
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clinical outcomes among individuals with a first episode psychosis attending Butabika National Mental Referral Hospital in Uganda: a longitudinal cohort study. A study protocol for a longitudinal cohort study.
    Akena D; Semeere A; Kadama P; Mwesiga E; Basangwa D; Nakku J; Nakasujja N
    BMJ Open; 2020 Jun; 10(6):e034367. PubMed ID: 32513876
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clarifying the direction of impact of negative symptoms and neurocognition on prospective work functioning in psychosis: A 20-year longitudinal study.
    Luther L; Suor JH; Rosen C; Jobe TH; Faull RN; Harrow M
    Schizophr Res; 2020 Jun; 220():232-239. PubMed ID: 32201031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.